查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2087574

脊神經刺激設備市場：按產品類型、技術、導線類型、應用和最終用戶分類的全球市場預測 – 2026-2032 年

Spinal Cord Neurostimulation Implant Market by Product Type, Technology, Lead Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，脊髓神經刺激設備的市場規模將成長至 40.2 億美元，複合年成長率為 8.31%。

主要市場統計數據
基準年 2025 23億美元
預計年份：2026年 24.7億美元
預測年份 2032 40.2億美元
複合年成長率 (%) 8.31%

脊髓神經刺激植入（也稱為脊髓刺激 (SCS) 系統）是一種可植入的神經調節裝置，用於治療保守治療、藥物或手術無法充分緩解疼痛的慢性神經病變疼痛。該技術通常結合了硬膜外電極、植入式脈衝產生器、臨床醫生程式設計軟體和患者控制器，以傳遞電脈衝來調節脊髓後柱的疼痛訊號。

推動需求成長的因素包括慢性疼痛的高發生率、非鴉片類鎮痛方法的日益普及，以及可充電和免充電植入式脈衝產生器技術的不斷進步。在美國，疾病管制與預防中心（CDC）的數據顯示，超過五分之一的成年人患有慢性疼痛，凸顯了持久性介入性鎮痛治療的臨床需求。美國食品藥物管理局（FDA）批准的脊髓刺激（SCS）適應症、更廣泛的臨床證據，以及保險公司對減少鴉片類藥物使用的治療方法日益成長的興趣，都在持續推動SCS在醫院、門診手術中心和疼痛診所的應用。

脊髓刺激療法領域的變革性變化

脊髓神經刺激植入領域正從基於傳統感覺異常的刺激轉向個人化、波形多樣化和回饋式治療。隨著高頻刺激、脈衝串刺激、差異化標靶連接複用方法和封閉回路型系統的出現，競爭格局正從單純的硬體可靠性轉向可衡量的患者療效、程式效率和長期治療依從性。

人工智慧（AI）對脊髓植入的累積影響

人工智慧 (AI) 正透過更聰明的患者篩選、預測性程式輔助、遠端監測和刺激參數的自動最佳化，開始影響脊髓神經刺激植入。 AI 驅動的分析能夠評估患者報告的結果、裝置使用模式、疼痛評分、睡眠變化和功能評估，從而識別僅靠間歇性追蹤難以發現的治療反應趨勢。

全球SCS採用的關鍵區域見解

北美地區在脊髓神經刺激設備的應用方面仍然最為成熟，這得益於其完善的疼痛治療網路、獲得FDA已通過核准的器械產品組合、公立和私立醫療保險報銷機制以及積極的臨床試驗活動。美國憑藉其龐大的慢性疼痛患者群體、疼痛專科醫生、門診手術中心的廣泛應用以及針對特定適應症的保險覆蓋，引領著該地區的脊髓神經刺激器應用。另一方面，加拿大則受益於其公共醫療保健系統下由專家主導的疼痛治療項目和成本效益評估。

關於東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵區域洞察

在東協地區，隨著新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國擴大疼痛管理服務，需求逐漸成長。然而，報銷制度的差異、人員配備的挑戰以及先進植入式技術的獲取不均等問題仍然阻礙著疼痛管理服務的普及。雖然新加坡和泰國在三級醫療和醫療旅遊方面相對領先，但東協其他較大的國家正在透過私立醫院網路和專科培訓來發展其疼痛管理系統。

各國脊髓神經刺激植入的關鍵訊息

美國是脊髓神經刺激植入領域最具創新性的市場，這得益於FDA的批准、疼痛專科醫生的密集分佈、保險覆蓋範圍、門診手術能力以及國家公共衛生數據所顯示的慢性疼痛高發率。加拿大則採取更集中的方式，其應用取決於各省的醫療資源、專科醫生的配備、醫療技術評估以及公共醫療體系的優先順序。墨西哥和巴西的私部門，尤其是大都會圈醫院，正在見證脊髓神經刺激植入物的普及。其中，巴西在神經調控領域處於區域領先地位，而墨西哥則藉鑒了美國的臨床實踐經驗以及與私立專科醫院的接近性。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化的臨床證據，這些證據需證明脊髓神經刺激設備植入能減輕疼痛、改善功能、減少鴉片類藥物的使用、提高睡眠品質、提升病患滿意度並改善調整生命年（QALY）。保險公司越來越期望獲得真實世界數據、長期耐久性數據、清晰的切除和再次手術追蹤記錄以及透明的患者選擇標準，因此參與註冊研究和進行上市後分析至關重要。

調查方法

本執行摘要採用二手資料調查方法，利用檢驗的資訊來源，包括監管資料庫、同儕審查的臨床文獻、政府衛生統計資料、保險公司政策文件、醫療設備指南和臨床實務資源。分析檢驗在於慢性疼痛、神經調控技術、臨床適應症、監管路徑、報銷趨勢、上市後監測預期以及區域醫療保健基礎設施等方面的已驗證趨勢。

結論

脊髓神經刺激設備市場正邁入一個更數據主導的階段。在這個階段，治療效果、個人化和數位化整合與設備小型化、電池性能和手術效率同等重要。隨著醫療系統探索非鴉片類藥物療法治療慢性神經病變疼痛，以及治療平台不斷擴展，配備先進的波形、兼容磁振造影的系統、封閉回路型功能和互聯護理工具，脊髓神經刺激（SCS）的戰略重要性日益凸顯。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 脊神經刺激設備市場：依產品類型分類

  • 不可充電
  • 可充電的

第8章 脊神經刺激設備市場：依技術分類

  • 閉合迴路
  • 開放回路

第9章 脊神經刺激設備市場：依導線類型分類

  • 經皮鉛
  • 槳鉛
  • 圓柱形鉛

第10章 脊神經刺激設備市場：依應用領域分類

  • 慢性疼痛管理
    • 脊椎手術後症候群（FBSS）
    • 椎間盤退化
    • 坐骨神經痛
    • 神經根病
  • 缺血性疼痛
  • 神經病變疼痛
  • 周圍血管疾病引起的疼痛

第11章 脊神經刺激設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 脊神經刺激設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 脊神經刺激設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 脊神經刺激設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Axonics, Inc.
  • Beijing PINS Medical Co., Ltd.
  • Biotronik SE & Co. KG
  • BlueWind Medical Ltd.
  • Boston Scientific Corporation
  • Cirtec Medical
  • Curonix LLC
  • Gimer Medical
  • Globus Medical, Inc.
  • Integer Holdings Corp.
  • LivaNova PLC
  • Mainstay Medical Limited
  • Medtronic plc
  • MicroTransponder Inc.
  • Nalu Medical, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Nevro Corp.
  • Saluda Medical Pty Ltd
  • SPR Therapeutics, Inc.
  • Stimwave Technologies, Inc.
  • Synapse Biomedical Inc.
  • Syntach AB
Product Code: MRR-0309FBC512F2

The Spinal Cord Neurostimulation Implant Market is projected to grow by USD 4.02 billion at a CAGR of 8.31% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.30 billion
Estimated Year [2026] USD 2.47 billion
Forecast Year [2032] USD 4.02 billion
CAGR (%) 8.31%

Spinal cord neurostimulation implants, also known as spinal cord stimulation (SCS) systems, are implantable neuromodulation devices used to manage chronic neuropathic pain when conservative therapy, medication, or surgery does not provide adequate relief. The technology typically combines epidural leads, an implantable pulse generator, clinician programming software, and patient controllers to deliver electrical pulses that modulate pain signaling in the dorsal columns of the spinal cord.

Demand is supported by the high burden of chronic pain, rising use of non-opioid pain management, and steady innovation in rechargeable and recharge-free implantable pulse generators. In the United States, CDC data show that chronic pain affects more than one in five adults, reinforcing the clinical need for durable interventional pain therapies. FDA-cleared SCS indications, broader clinical evidence, and payer attention to opioid-sparing care continue to shape adoption across hospitals, ambulatory surgery centers, and pain specialty clinics.

Transformative Shifts in the Spinal Cord Stimulation Landscape

The spinal cord neurostimulation implant landscape is shifting from conventional paresthesia-based stimulation toward personalized, waveform-diverse, and feedback-enabled therapy. High-frequency stimulation, burst stimulation, differential target multiplexed approaches, and closed-loop systems are changing the competitive basis from hardware reliability alone to measurable patient outcomes, programming efficiency, and long-term therapy adherence.

A second structural shift is the move toward minimally disruptive care pathways. Same-day procedures, improved imaging guidance, smaller pulse generators, expanded MRI-conditional labeling, and remote patient support are improving the fit of SCS within value-based care. Device developers are also competing on implant longevity, charging burden, digital ecosystem integration, and evidence generation for painful diabetic neuropathy, failed back surgery syndrome, complex regional pain syndrome, and refractory low back and leg pain.

Cumulative Impact of Artificial Intelligence on SCS Implants

Artificial intelligence is beginning to influence spinal cord neurostimulation implants through smarter patient selection, predictive programming support, remote monitoring, and automated optimization of stimulation parameters. AI-enabled analytics can evaluate patient-reported outcomes, device usage patterns, pain scores, sleep changes, and functional measures to identify therapy response trends that are difficult to detect through episodic clinic visits alone.

The most meaningful near-term impact is operational rather than fully autonomous therapy. AI can help clinicians shorten programming time, reduce trial-to-implant uncertainty, flag declining adherence, and personalize follow-up cadence. Over time, integration with closed-loop sensing, electronic health records, and real-world evidence platforms may support adaptive neuromodulation models, while regulatory expectations for transparency, cybersecurity, clinical validation, and bias control will remain central to commercialization.

Key Regional Insights Across Global SCS Adoption

North America remains the most mature region for spinal cord neurostimulation implants due to established interventional pain networks, FDA-cleared device portfolios, private and public reimbursement pathways, and strong clinical trial activity. The United States drives regional adoption through a large chronic pain population, specialist pain practices, ambulatory surgery center utilization, and payer coverage for selected indications, while Canada benefits from specialist-led pain programs and public health system evaluation of cost-effectiveness.

Europe shows broad clinical expertise and structured adoption in Western markets, particularly where national health technology assessment supports reimbursement and long-term evidence review. The European Union's Medical Device Regulation has raised clinical evidence and post-market surveillance requirements, increasing compliance complexity while strengthening confidence in device safety and performance. The United Kingdom, Germany, France, Italy, and Spain remain important procedural hubs, supported by multidisciplinary pain services and established neuromodulation expertise.

Asia-Pacific is expanding as Japan, Australia, South Korea, China, and India invest in advanced pain care, hospital infrastructure, and local specialist training. Japan and Australia benefit from mature regulatory and clinical pathways, South Korea is supported by technologically advanced hospitals, and China and India are gaining relevance as chronic disease burden, spine care needs, and private hospital capacity increase. Latin America, led by Brazil and Mexico, is developing through private hospital adoption and growing awareness of neuromodulation. The Middle East is supported by premium hospital systems in GCC markets, particularly in tertiary care and medical tourism settings, while Africa remains earlier-stage, with adoption concentrated in major urban private hospitals and academic centers.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand is rising gradually as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines expand specialty pain services, although reimbursement variability, workforce availability, and unequal access to advanced implantable technologies continue to limit uniform adoption. Singapore and Thailand are comparatively more advanced in tertiary care and medical tourism, while larger ASEAN countries are building capacity through private hospital networks and specialist training.

The GCC shows stronger near-term readiness because Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman are investing in tertiary hospitals, digital health infrastructure, medical tourism, and advanced implantable medical technologies. The European Union is defined by rigorous clinical evidence expectations, MDR compliance, and country-level reimbursement pathways, making it attractive but operationally demanding for spinal cord stimulation implants.

BRICS markets combine large patient pools with uneven access; China and India offer scale through rising chronic pain, diabetes-related neuropathy, and spine disease treatment needs, Brazil provides Latin American leadership in private-sector neuromodulation, and South Africa and Russia remain more concentrated in specialized centers. G7 countries represent the strongest evidence, reimbursement, regulatory, and innovation base for SCS implants, supported by advanced pain medicine networks. NATO countries overlap heavily with advanced European and North American systems, supporting procurement reliability, regulatory alignment, specialist training, and high clinical standards.

Key Country Insights in Spinal Cord Neurostimulation Implants

The United States is the most innovation-intensive country market for spinal cord neurostimulation implants, supported by FDA clearances, pain specialist density, payer coverage, ambulatory procedure capacity, and a high chronic pain burden documented by national public health data. Canada follows a more centralized pathway, where adoption depends on provincial access, specialist availability, health technology assessment, and public system prioritization. Mexico and Brazil show growing private-sector adoption, particularly in large metropolitan hospitals, with Brazil leading regional neuromodulation expertise and Mexico benefiting from proximity to U.S. clinical practices and private specialty care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are central to SCS utilization because of established pain medicine communities, neurosurgical and anesthesiology expertise, and reimbursement frameworks that emphasize clinical appropriateness. Germany is especially important for high-acuity hospital care and medical device evaluation, while France and the United Kingdom emphasize evidence-based adoption, multidisciplinary review, and payer scrutiny. Italy and Spain maintain active specialist networks and hospital-based implantation pathways, while Russia remains more variable due to access, procurement, and regional healthcare infrastructure constraints.

In Asia-Pacific, Japan benefits from advanced device regulation, an aging population, and sophisticated hospital systems, while Australia has strong specialist adoption, private insurance participation, and clinical guideline awareness. South Korea combines high hospital capability with digital health readiness and rapid adoption of advanced medical technologies. China and India represent long-term volume opportunities as chronic disease burden, spine care demand, diabetes-related neuropathy, and private hospital capacity expand, although reimbursement, affordability, specialist distribution, and regional access differences continue to shape adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence that links spinal cord neurostimulation implants to pain reduction, functional improvement, opioid reduction, sleep quality, patient satisfaction, and quality-adjusted outcomes. Payers increasingly expect real-world evidence, long-term durability data, clear explant and revision tracking, and transparent criteria for patient selection, making registry participation and post-market analytics essential.

Device developers should invest in AI-supported programming, remote care tools, cybersecurity, MRI compatibility, lead reliability, and battery innovation while simplifying clinician workflows. Commercial teams should localize strategies by reimbursement maturity: evidence-led contracting in North America and Europe, specialist training in Asia-Pacific, premium-center targeting in the GCC, and private hospital partnerships in Latin America and Africa. Leaders should also strengthen patient education, multidisciplinary referral pathways, and responsible data governance to improve access and therapy adherence.

Research Methodology

This executive summary applies a secondary research methodology using verified public sources, including regulatory databases, peer-reviewed clinical literature, government health statistics, payer policy documents, medical device guidance, and clinical practice resources. The analysis emphasizes validated trends in chronic pain, neuromodulation technology, clinical indications, regulatory pathways, reimbursement dynamics, post-market surveillance expectations, and regional healthcare infrastructure.

Insights were synthesized through market triangulation, comparing clinical adoption drivers with device innovation, payer readiness, country-level healthcare access, specialist availability, and regulatory requirements. Claims are intentionally framed around documented industry patterns rather than unsupported market-size figures, ensuring the analysis remains evidence-based, and suitable for strategic decision-making.

Conclusion

The spinal cord neurostimulation implant market is entering a more data-driven phase, where outcomes, personalization, and digital integration matter as much as device miniaturization, battery performance, and procedural efficiency. SCS continues to gain strategic relevance as health systems seek non-opioid options for chronic neuropathic pain and as therapy platforms expand with advanced waveforms, MRI-conditional systems, closed-loop capabilities, and connected care tools.

Future adoption will depend on strong clinical evidence, reimbursement alignment, responsible AI deployment, cybersecurity readiness, and equitable access to specialist pain care. Organizations that combine validated outcomes, clinician-friendly workflows, rigorous post-market evidence, and region-specific commercialization models will be best positioned to lead the next stage of spinal cord stimulation adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Spinal Cord Neurostimulation Implant Market, by Product Type

  • 7.1. Non Rechargeable
  • 7.2. Rechargeable

8. Spinal Cord Neurostimulation Implant Market, by Technology

  • 8.1. Closed Loop
  • 8.2. Open Loop

9. Spinal Cord Neurostimulation Implant Market, by Lead Type

  • 9.1. Percutaneous Leads
  • 9.2. Paddle Leads
  • 9.3. Cylindrical Leads

10. Spinal Cord Neurostimulation Implant Market, by Application

  • 10.1. Chronic Pain Management
    • 10.1.1. Failed Back Surgery Syndrome (FBSS)
    • 10.1.2. Degenerative Disc Disease
    • 10.1.3. Sciatica
    • 10.1.4. Radicular Pain
  • 10.2. Ischemic Pain
  • 10.3. Neuropathic Pain
  • 10.4. Peripheral Vascular Disease Pain

11. Spinal Cord Neurostimulation Implant Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Spinal Cord Neurostimulation Implant Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Spinal Cord Neurostimulation Implant Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Spinal Cord Neurostimulation Implant Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Aleva Neurotherapeutics SA
  • 16.3. Axonics, Inc.
  • 16.4. Beijing PINS Medical Co., Ltd.
  • 16.5. Biotronik SE & Co. KG
  • 16.6. BlueWind Medical Ltd.
  • 16.7. Boston Scientific Corporation
  • 16.8. Cirtec Medical
  • 16.9. Curonix LLC
  • 16.10. Gimer Medical
  • 16.11. Globus Medical, Inc.
  • 16.12. Integer Holdings Corp.
  • 16.13. LivaNova PLC
  • 16.14. Mainstay Medical Limited
  • 16.15. Medtronic plc
  • 16.16. MicroTransponder Inc.
  • 16.17. Nalu Medical, Inc.
  • 16.18. NeuroPace, Inc.
  • 16.19. NeuroSigma, Inc.
  • 16.20. Nevro Corp.
  • 16.21. Saluda Medical Pty Ltd
  • 16.22. SPR Therapeutics, Inc.
  • 16.23. Stimwave Technologies, Inc.
  • 16.24. Synapse Biomedical Inc.
  • 16.25. Syntach AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON RECHARGEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON RECHARGEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON RECHARGEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RECHARGEABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RECHARGEABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RECHARGEABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OPEN LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OPEN LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL OPEN LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PADDLE LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PADDLE LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PADDLE LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CYLINDRICAL LEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CYLINDRICAL LEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CYLINDRICAL LEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CHRONIC PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FAILED BACK SURGERY SYNDROME (FBSS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FAILED BACK SURGERY SYNDROME (FBSS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FAILED BACK SURGERY SYNDROME (FBSS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SCIATICA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SCIATICA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SCIATICA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADICULAR PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADICULAR PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADICULAR PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ISCHEMIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ISCHEMIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ISCHEMIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROPATHIC PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DISEASE PAIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DISEASE PAIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DISEASE PAIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 118. GCC SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. G7 SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 146. NATO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 161. CANADA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 168. MEXICO SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 175. BRAZIL SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED KINGDOM SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 189. GERMANY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 196. FRANCE SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 203. RUSSIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. ITALY SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. SPAIN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 231. INDIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 238. JAPAN SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 245. AUSTRALIA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY LEAD TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY CHRONIC PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 252. SOUTH KOREA SPINAL CORD NEUROSTIMULATION IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)